What has changed
The federal Department of Health, Disability and Ageing registered a new legislative instrument on 13 August 2026 that amends the rules around accreditation for transcatheter valve therapies under the Health Insurance Act 1973. The instrument is listed as in force on the Federal Register of Legislation as of 13 August 2026.
What are transcatheter valve therapies
Transcatheter valve therapies are minimally invasive heart valve procedures.
What the instrument covers
The instrument amends the accreditation rules that apply to transcatheter valve therapies. The source page on the Federal Register of Legislation does not provide detail on what specific accreditation changes have been made. The full text of the determination and its explanatory statement are available at https://www.legislation.gov.au/F2026L01052.
Key actions
- Read the full determination and its explanatory statement at https://www.legislation.gov.au/F2026L01052 if your practice performs or bills for transcatheter valve therapy procedures.
- Check with your accreditation body or the Department of Health, Disability and Ageing to confirm whether your facility's existing accreditation status is affected by this change.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.